{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T22:43:47Z","timestamp":1791931427124,"version":"4.3.4"},"reference-count":89,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","nmd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuromuscular Disorders"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.nmd.2025.105363","type":"journal-article","created":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T02:08:47Z","timestamp":1744164527000},"page":"105363","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Emerging atypical clinicopathological manifestations of immune-mediated necrotizing myopathy (IMNM)"],"prefix":"10.1016","volume":"50","author":[{"given":"Michael P.","family":"Skolka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iago","family":"Pinal-Fernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew L.","family":"Mammen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0212-5697","authenticated-orcid":false,"given":"Teerin","family":"Liewluck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.nmd.2025.105363_bib0001","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.nmd.2017.09.016","article-title":"Immune-mediated Necrotizing myopathies Working G. 224th ENMC international workshop:: clinico-sero-pathological classification of immune-mediated necrotizing myopathies Zandvoort, The Netherlands, 14-16 October 2016","volume":"28","author":"Allenbach","year":"2018","journal-title":"Neuromuscul Disord"},{"issue":"9","key":"10.1016\/j.nmd.2025.105363_bib0002","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1001\/jamaneurol.2015.1207","article-title":"Clinical features and treatment outcomes of necrotizing autoimmune myopathy","volume":"72","author":"Kassardjian","year":"2015","journal-title":"JAMA Neurol"},{"issue":"1","key":"10.1016\/j.nmd.2025.105363_bib0003","doi-asserted-by":"crossref","first-page":"e513","DOI":"10.1212\/NXI.0000000000000513","article-title":"Seronegative patients form a distinctive subgroup of immune-mediated necrotizing myopathy","volume":"6","author":"Lim","year":"2019","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"2","key":"10.1016\/j.nmd.2025.105363_bib0004","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/bpa.12772","article-title":"Sequestosome-1 (p62) expression reveals chaperone-assisted selective autophagy in immune-mediated necrotizing myopathies","volume":"30","author":"Fischer","year":"2020","journal-title":"Brain Pathol"},{"issue":"2","key":"10.1016\/j.nmd.2025.105363_bib0005","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/path.1710970204","article-title":"Skeletal muscle necrosis associated with cainoma","volume":"97","author":"Smith","year":"1969","journal-title":"J Pathol"},{"issue":"24","key":"10.1016\/j.nmd.2025.105363_bib0006","doi-asserted-by":"crossref","first-page":"9507","DOI":"10.1073\/pnas.83.24.9507","article-title":"Human autoantibodies reactive with the signal-recognition particle","volume":"83","author":"Reeves","year":"1986","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"10.1016\/j.nmd.2025.105363_bib0007","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.nmd.2004.02.006","article-title":"119th ENMC international workshop: trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis, 10-12 October 2003, Naarden, The Netherlands","volume":"14","author":"Hoogendijk","year":"2004","journal-title":"Neuromuscul Disord"},{"issue":"3","key":"10.1016\/j.nmd.2025.105363_bib0008","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1002\/art.30156","article-title":"Autoantibodies against 3-hydroxy-3-methylglutaryl-coenzyme A reductase in patients with statin-associated autoimmune myopathy","volume":"63","author":"Mammen","year":"2011","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.nmd.2025.105363_bib0009","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1002\/mus.27435","article-title":"Immune-mediated necrotizing myopathy: unusual presentations of a treatable disease","volume":"64","author":"Nicolau","year":"2021","journal-title":"Muscle Nerve"},{"issue":"7","key":"10.1016\/j.nmd.2025.105363_bib0010","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1212\/WNL.0000000000007952","article-title":"Necrotizing autoimmune myopathy with tubular aggregates","volume":"93","author":"Madigan","year":"2019","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.nmd.2025.105363_bib0011","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1002\/mus.27504","article-title":"Incidence and prevalence of immune-mediated necrotizing myopathy in adults in Olmsted County","volume":"65","author":"Shelly","year":"2022","journal-title":"Minnesota Muscle Nerve"},{"issue":"12","key":"10.1016\/j.nmd.2025.105363_bib0012","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2023.103468","article-title":"Anti-HMGCR immune-mediated necrotising myopathy: addressing the remaining issues","volume":"22","author":"Khoo","year":"2023","journal-title":"Autoimmun Rev"},{"issue":"2","key":"10.1016\/j.nmd.2025.105363_bib0013","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1002\/mus.27758","article-title":"Necrotizing myopathy with elevated anti-HMGCR antibodies following exposure to the supplement Bacopa","volume":"67","author":"Yaworski","year":"2023","journal-title":"Muscle Nerve"},{"issue":"7","key":"10.1016\/j.nmd.2025.105363_bib0014","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1056\/NEJMra1515161","article-title":"Statin-associated autoimmune myopathy","volume":"374","author":"Mammen","year":"2016","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.nmd.2025.105363_bib0015","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s11926-018-0732-6","article-title":"Immune-mediated necrotizing myopathy","volume":"20","author":"Pinal-Fernandez","year":"2018","journal-title":"Curr Rheumatol Rep"},{"issue":"9","key":"10.1016\/j.nmd.2025.105363_bib0016","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1002\/art.42126","article-title":"Increased risk of statin-associated autoimmune myopathy among American Indians","volume":"74","author":"Wei","year":"2022","journal-title":"Arthritis Rheumatol"},{"issue":"2","key":"10.1016\/j.nmd.2025.105363_bib0017","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1093\/rheumatology\/keaa337","article-title":"Potential implications of six American Indian patients with myopathy, statin exposure and anti-HMGCR antibodies","volume":"60","author":"Close","year":"2021","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"10.1016\/j.nmd.2025.105363_bib0018","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/imj.13575","article-title":"Statin-associated immune-mediated necrotising myopathy: a New Zealand case series showing possible overrepresentation in Pacific Islanders","volume":"48","author":"Woolley","year":"2018","journal-title":"Intern Med J"},{"issue":"6","key":"10.1016\/j.nmd.2025.105363_bib0019","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1111\/imj.13816","article-title":"Over-representation of statin-associated necrotising myopathy in patients of Aboriginal and Torres Strait Islander heritage","volume":"48","author":"Day","year":"2018","journal-title":"Intern Med J"},{"issue":"2","key":"10.1016\/j.nmd.2025.105363_bib0020","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1002\/acr.22920","article-title":"Longitudinal course of disease in a large cohort of myositis patients with autoantibodies recognizing the signal recognition particle","volume":"69","author":"Pinal-Fernandez","year":"2017","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"4","key":"10.1016\/j.nmd.2025.105363_bib0021","doi-asserted-by":"crossref","first-page":"488","DOI":"10.3899\/jrheum.160871","article-title":"Anti-HMGCR autoantibodies in juvenile idiopathic inflammatory myopathies identify a rare but clinically important subset of patients","volume":"44","author":"Tansley","year":"2017","journal-title":"J Rheumatol"},{"issue":"2","key":"10.1016\/j.nmd.2025.105363_bib0022","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.pediatrneurol.2011.04.009","article-title":"Anti-signal recognition particle myopathy in the first decade of life","volume":"45","author":"Suzuki","year":"2011","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.nmd.2025.105363_bib0023","article-title":"Pediatric immune-mediated necrotizing myopathy","volume":"14","author":"Wang","year":"2023","journal-title":"Front Neurol"},{"key":"10.1016\/j.nmd.2025.105363_bib0024","doi-asserted-by":"crossref","DOI":"10.1016\/j.semarthrit.2024.152522","article-title":"Anti-HMGCR myopathy: diversity of clinical presentations in a national cohort in New Zealand","volume":"68","author":"Chow","year":"2024","journal-title":"Semin Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.nmd.2025.105363_bib0025","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/nan.12380","article-title":"Integrated classification of inflammatory myopathies","volume":"43","author":"Allenbach","year":"2017","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"6","key":"10.1016\/j.nmd.2025.105363_bib0026","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1097\/BOR.0000000000000836","article-title":"Differential diagnosis of necrotizing myopathy","volume":"33","author":"Selva-O'Callaghan","year":"2021","journal-title":"Curr Opin Rheumatol"},{"issue":"3","key":"10.1016\/j.nmd.2025.105363_bib0027","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.nmd.2020.02.003","article-title":"Clinical and histological features of immune-mediated necrotising myopathy: a multi-centre South Australian cohort study","volume":"30","author":"Day","year":"2020","journal-title":"Neuromuscul Disord"},{"issue":"10","key":"10.1016\/j.nmd.2025.105363_bib0028","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1016\/j.mayocp.2020.03.032","article-title":"Cardiac and Respiratory complications of necrotizing autoimmune myopathy","volume":"95","author":"Triplett","year":"2020","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.nmd.2025.105363_bib0029","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2021.102691","article-title":"Cutaneous involvement in anti-HMGCR positive necrotizing myopathy","volume":"123","author":"Williams","year":"2021","journal-title":"J Autoimmun"},{"issue":"2","key":"10.1016\/j.nmd.2025.105363_bib0030","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1001\/jamadermatol.2024.5266","article-title":"Jessner lymphocytic infiltrate in anti-HMGCR myopathy","volume":"161","author":"Prenner","year":"2025","journal-title":"JAMA Dermatol"},{"issue":"1","key":"10.1016\/j.nmd.2025.105363_bib0031","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s12865-024-00622-2","article-title":"Atypical skin conditions of the neck and back as a dermal manifestation of anti-HMGCR antibody-positive myopathy","volume":"25","author":"Kurashige","year":"2024","journal-title":"BMC Immunol"},{"issue":"4","key":"10.1016\/j.nmd.2025.105363_bib0032","doi-asserted-by":"crossref","first-page":"570","DOI":"10.31138\/mjr.220823.imc","article-title":"A challenging inflammatory myopathy case-report: dermatomyositis-like rash in an anti-HMGCR positive patient with an uncertain muscle histology","volume":"34","author":"Parente","year":"2023","journal-title":"Mediterr J Rheumatol"},{"issue":"1","key":"10.1016\/j.nmd.2025.105363_bib0033","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s12890-021-01802-1","article-title":"Interstitial lung disease is not rare in immune-mediated necrotizing myopathy with anti-signal recognition particle antibodies","volume":"22","author":"Ge","year":"2022","journal-title":"BMC Pulm Med"},{"issue":"8","key":"10.1016\/j.nmd.2025.105363_bib0034","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1093\/rheumatology\/keaa021","article-title":"The reliability of immunoassays to detect autoantibodies in patients with myositis is dependent on autoantibody specificity","volume":"59","author":"Tansley","year":"2020","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"10.1016\/j.nmd.2025.105363_bib0035","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/acr.20662","article-title":"Rarity of anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase antibodies in statin users, including those with self-limited musculoskeletal side effects","volume":"64","author":"Mammen","year":"2012","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"12","key":"10.1016\/j.nmd.2025.105363_bib0036","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/s41584-020-00515-9","article-title":"Immune-mediated necrotizing myopathy: clinical features and pathogenesis","volume":"16","author":"Allenbach","year":"2020","journal-title":"Nat Rev Rheumatol"},{"issue":"2","key":"10.1016\/j.nmd.2025.105363_bib0037","doi-asserted-by":"crossref","first-page":"fcaa181","DOI":"10.1093\/braincomms\/fcaa181","article-title":"Immune checkpoint inhibitor-associated myopathy: a clinicoseropathologically distinct myopathy","volume":"2","author":"Shelly","year":"2020","journal-title":"Brain Commun"},{"issue":"11","key":"10.1016\/j.nmd.2025.105363_bib0038","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000210031","article-title":"Immune checkpoint inhibitor myopathy: the double-edged sword of cancer immunotherapy","volume":"103","author":"Beecher","year":"2024","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.nmd.2025.105363_bib0039","doi-asserted-by":"crossref","first-page":"e507","DOI":"10.1212\/WNL.0000000000004923","article-title":"Necrosis in anti-SRP(+) and anti-HMGCR(+)myopathies: role of autoantibodies and complement","volume":"90","author":"Allenbach","year":"2018","journal-title":"Neurology"},{"issue":"11","key":"10.1016\/j.nmd.2025.105363_bib0040","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1136\/ard-2024-225773","article-title":"Pathological autoantibody internalisation in myositis","volume":"83","author":"Pinal-Fernandez","year":"2024","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"10.1016\/j.nmd.2025.105363_bib0041","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.nmd.2022.03.005","article-title":"Mitochondrial dysfunction in anti-3-hydroxy-3-methylglutaryl-CoA reductase (HMGCR) immune-mediated necrotising myopathy","volume":"32","author":"Acosta","year":"2022","journal-title":"Neuromuscul Disord"},{"issue":"4","key":"10.1016\/j.nmd.2025.105363_bib0042","doi-asserted-by":"crossref","first-page":"e124","DOI":"10.1212\/NXI.0000000000000124","article-title":"Myopathy with anti-HMGCR antibodies: perimysium and myofiber pathology","volume":"2","author":"Alshehri","year":"2015","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"1","key":"10.1016\/j.nmd.2025.105363_bib0043","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s00401-023-02669-8","article-title":"Complement and MHC patterns can provide the diagnostic framework for inflammatory neuromuscular diseases","volume":"147","author":"Nelke","year":"2024","journal-title":"Acta Neuropathol"},{"issue":"12","key":"10.1016\/j.nmd.2025.105363_bib0044","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1093\/jnen\/nlae098","article-title":"Contribution of major histocompatibility complex class II immunostaining in distinguishing idiopathic inflammatory myopathy subgroups: a histopathological cohort study","volume":"83","author":"Lessard","year":"2024","journal-title":"J Neuropathol Exp Neurol"},{"issue":"1","key":"10.1016\/j.nmd.2025.105363_bib0045","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/mus.27739","article-title":"Autophagy in non-immune-mediated rhabdomyolysis: assessment of p62 immunohistochemistry","volume":"67","author":"Acosta","year":"2023","journal-title":"Muscle Nerve"},{"issue":"3","key":"10.1016\/j.nmd.2025.105363_bib0046","first-page":"3069","article-title":"CD4+ cells, macrophages, MHC-I and C5b-9 involve the pathogenesis of dysferlinopathy","volume":"8","author":"Yin","year":"2015","journal-title":"Int J Clin Exp Pathol"},{"issue":"2","key":"10.1016\/j.nmd.2025.105363_bib0047","doi-asserted-by":"crossref","first-page":"351","DOI":"10.55563\/clinexprheumatol\/6mp37n","article-title":"Accumulation of autophagosome cargo protein p62 is common in idiopathic inflammatory myopathies","volume":"39","author":"Milisenda","year":"2021","journal-title":"Clin Exp Rheumatol"},{"issue":"Pt 8","key":"10.1016\/j.nmd.2025.105363_bib0048","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1093\/brain\/aww054","article-title":"High risk of cancer in autoimmune necrotizing myopathies: usefulness of myositis specific antibody","volume":"139","author":"Allenbach","year":"2016","journal-title":"Brain"},{"issue":"2","key":"10.1016\/j.nmd.2025.105363_bib0049","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1002\/mus.28114","article-title":"Management of immune-mediated necrotizing myopathy","volume":"70","author":"Suh","year":"2024","journal-title":"Muscle Nerve"},{"issue":"1","key":"10.1016\/j.nmd.2025.105363_bib0050","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s13075-019-2093-6","article-title":"Statin-induced anti-HMGCR myopathy: successful therapeutic strategies for corticosteroid-free remission in 55 patients","volume":"22","author":"Meyer","year":"2020","journal-title":"Arthritis Res Ther"},{"issue":"17","key":"10.1016\/j.nmd.2025.105363_bib0051","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1056\/NEJMc1506163","article-title":"Intravenous immune globulin for statin-triggered autoimmune myopathy","volume":"373","author":"Mammen","year":"2015","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.nmd.2025.105363_bib0052","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1007\/s40674-023-00210-2","article-title":"Pinal-Fernandez I. Treatment of immune-mediated necrotizing myopathy","volume":"9","author":"Ogbonnaya-Whittlesey","year":"2023","journal-title":"Curr Treatm Opt Rheumatol"},{"issue":"2","key":"10.1016\/j.nmd.2025.105363_bib0053","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1093\/rheumatology\/kew386","article-title":"Pediatric necrotizing myopathy associated with anti-3-hydroxy-3-methylglutaryl-coenzyme a reductase antibodies","volume":"56","author":"Liang","year":"2017","journal-title":"Rheumatology (Oxford)"},{"issue":"3","key":"10.1016\/j.nmd.2025.105363_bib0054","doi-asserted-by":"crossref","first-page":"e5694","DOI":"10.1097\/MD.0000000000005694","article-title":"Atorvastatin-induced necrotizing autoimmune myositis: an emerging dominant entity in patients with autoimmune myositis presenting with a pure polymyositis phenotype","volume":"96","author":"Troyanov","year":"2017","journal-title":"Medicine"},{"issue":"1","key":"10.1016\/j.nmd.2025.105363_bib0055","doi-asserted-by":"crossref","first-page":"e523","DOI":"10.1212\/NXI.0000000000000523","article-title":"Anti-HMGCR myopathy may resemble limb-girdle muscular dystrophy","volume":"6","author":"Mohassel","year":"2019","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"10","key":"10.1016\/j.nmd.2025.105363_bib0056","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2020-235457","article-title":"Alves de Siqueira Carvalho A. Immune-mediated necrotising myopathy in asymptomatic patients with high creatine kinase","volume":"13","author":"Soares","year":"2020","journal-title":"BMJ Case Rep"},{"issue":"3","key":"10.1016\/j.nmd.2025.105363_bib0057","doi-asserted-by":"crossref","DOI":"10.1002\/mus.26388","article-title":"Anti-SRP associated necrotizing autoimmune myopathy presenting with asymptomatically elevated creatine kinase","volume":"59","author":"Triplett","year":"2019","journal-title":"Muscle Nerve"},{"issue":"3","key":"10.1016\/j.nmd.2025.105363_bib0058","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s10067-014-2512-7","article-title":"Inflammatory myopathy with anti-SRP antibodies: case series of a South Australian cohort","volume":"34","author":"Basnayake","year":"2015","journal-title":"Clin Rheumatol"},{"issue":"2","key":"10.1016\/j.nmd.2025.105363_bib0059","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.nmd.2022.12.012","article-title":"A young female case of asymptomatic immune-mediated necrotizing myopathy: a potential diagnostic option of antibody testing for rhabdomyolysis","volume":"33","author":"Sasaki","year":"2023","journal-title":"Neuromuscul Disord"},{"issue":"5","key":"10.1016\/j.nmd.2025.105363_bib0060","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/j.mayocp.2016.12.025","article-title":"Diagnosis and management of immune-mediated myopathies","volume":"92","author":"Milone","year":"2017","journal-title":"Mayo Clin Proc"},{"issue":"2","key":"10.1016\/j.nmd.2025.105363_bib0061","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/mus.26077","article-title":"Untangling the complexity of limb-girdle muscular dystrophies","volume":"58","author":"Liewluck","year":"2018","journal-title":"Muscle Nerve"},{"issue":"6","key":"10.1016\/j.nmd.2025.105363_bib0062","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1055\/s-0037-1604402","article-title":"Anti-HMGCR antibody-related necrotizing autoimmune myopathy mimicking muscular dystrophy","volume":"48","author":"Tard","year":"2017","journal-title":"Neuropediatrics"},{"key":"10.1016\/j.nmd.2025.105363_bib0063","first-page":"1","article-title":"The first reported familial case of statin-induced immune-mediated necrotizing myopathy associated with anti-hydroxy-3-methylglutaryl-CoA reductase autoantibodies and HLA DRB1\u00d711:01","author":"Bronchain","year":"2024","journal-title":"Acta Clin Belg"},{"issue":"1","key":"10.1016\/j.nmd.2025.105363_bib0064","article-title":"Anti-HMGCR myopathy mimicking facioscapulohumeral muscular dystrophy","volume":"19","author":"Braun","year":"2024","journal-title":"Open Med (Wars)"},{"issue":"6","key":"10.1016\/j.nmd.2025.105363_bib0065","first-page":"1735","article-title":"Facioscapulohumeral muscular dystrophy","volume":"28","author":"Mul","year":"2022","journal-title":"Continuum (Minneap Minn)"},{"issue":"4","key":"10.1016\/j.nmd.2025.105363_bib0066","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/CND.0000000000000115","article-title":"Chronic myopathy associated with anti-signal recognition particle antibodies can Be misdiagnosed As facioscapulohumeral muscular dystrophy","volume":"17","author":"Ikeda","year":"2016","journal-title":"J Clin Neuromuscul Dis"},{"issue":"3","key":"10.1016\/j.nmd.2025.105363_bib0067","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1002\/art.41964","article-title":"Performance of the 2017 European alliance of associations for rheumatology\/American college of rheumatology classification criteria for idiopathic inflammatory myopathies in patients with myositis-specific autoantibodies","volume":"74","author":"Casal-Dominguez","year":"2022","journal-title":"Arthritis Rheumatol"},{"issue":"2","key":"10.1016\/j.nmd.2025.105363_bib0068","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.nmd.2021.11.010","article-title":"Unusual cases of anti-SRP necrotizing myopathy with predominant distal leg weakness and atrophy","volume":"32","author":"Moshe-Lilie","year":"2022","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2025.105363_bib0069","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s12901-016-0027-3","article-title":"A case report of autoimmune necrotizing myositis presenting as dysphagia and neck swelling","volume":"16","author":"Ngo","year":"2016","journal-title":"BMC Ear Nose Throat Disord"},{"issue":"5","key":"10.1016\/j.nmd.2025.105363_bib0070","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2018-229119","article-title":"Atypical presentation of necrotising autoimmune myopathy","volume":"12","author":"Ajiboye","year":"2019","journal-title":"BMJ Case Rep"},{"issue":"3","key":"10.1016\/j.nmd.2025.105363_bib0071","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1002\/mus.26996","article-title":"Myopathies featuring early or prominent dysphagia","volume":"62","author":"Triplett","year":"2020","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nmd.2025.105363_bib0072","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nmd.2024.06.005","article-title":"Ophthalmoparesis as an unusual manifestation of anti-3\u2011hydroxy-3-methyl-glutaryl-coenzyme A reductase antibody-associated myopathies","volume":"42","author":"Putko","year":"2024","journal-title":"Neuromuscul Disord"},{"issue":"7","key":"10.1016\/j.nmd.2025.105363_bib0073","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/j.clineuro.2011.12.055","article-title":"Unusual manifestations in two cases of necrotizing myopathy associated with SRP-antibodies","volume":"114","author":"Hanisch","year":"2012","journal-title":"Clin Neurol Neurosurg"},{"issue":"3","key":"10.1016\/j.nmd.2025.105363_bib0074","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.nmd.2010.12.007","article-title":"Myofibrillar myopathies","volume":"21","author":"Selcen","year":"2011","journal-title":"Neuromuscul Disord"},{"issue":"3","key":"10.1016\/j.nmd.2025.105363_bib0075","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.ncl.2020.04.002","volume":"38","author":"Hussain","year":"2020","journal-title":"Neurol Clin"},{"issue":"2","key":"10.1016\/j.nmd.2025.105363_bib0076","doi-asserted-by":"crossref","first-page":"fcae041","DOI":"10.1093\/braincomms\/fcae041","article-title":"Mitochondrial myopathies diagnosed in adulthood: clinico-genetic spectrum and long-term outcomes","volume":"6","author":"Beecher","year":"2024","journal-title":"Brain Commun"},{"issue":"7","key":"10.1016\/j.nmd.2025.105363_bib0077","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.nmd.2019.05.007","article-title":"Concurrent positive anti-3-hydroxy-3-methylglutaryl-coenzyme a reductase antibody with reducing body myopathy: possible double trouble","volume":"29","author":"Tanboon","year":"2019","journal-title":"Neuromuscul Disord"},{"issue":"4","key":"10.1016\/j.nmd.2025.105363_bib0078","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1136\/annrheumdis-2016-210198","article-title":"Thigh muscle MRI in immune-mediated necrotising myopathy: extensive oedema, early muscle damage and role of anti-SRP autoantibodies as a marker of severity","volume":"76","author":"Pinal-Fernandez","year":"2017","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"10.1016\/j.nmd.2025.105363_bib0079","doi-asserted-by":"crossref","first-page":"2556","DOI":"10.1093\/rheumatology\/keac668","article-title":"Symptomatic myopathies in sarcoidosis: disease spectrum and myxovirus resistance protein A expression","volume":"62","author":"Chompoopong","year":"2023","journal-title":"Rheumatology (Oxford)"},{"issue":"3","key":"10.1016\/j.nmd.2025.105363_bib0080","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/mus.27741","article-title":"Granulomatous myopathy: sarcoidosis and beyond","volume":"67","author":"Chompoopong","year":"2023","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nmd.2025.105363_bib0081","doi-asserted-by":"crossref","DOI":"10.1016\/j.clineuro.2023.107844","article-title":"Granulomatous myopathy co-existent immune-mediated necrotizing myopathy: a case report","volume":"232","author":"Yin","year":"2023","journal-title":"Clin Neurol Neurosurg"},{"issue":"3","key":"10.1016\/j.nmd.2025.105363_bib0082","doi-asserted-by":"crossref","first-page":"e85","DOI":"10.1093\/rheumatology\/keaa530","article-title":"A unique case of co-existent sarcoidosis and immune-mediated necrotizing myopathy","volume":"60","author":"Koller-Smith","year":"2021","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"10.1016\/j.nmd.2025.105363_bib0083","first-page":"341","article-title":"Pulmonary sarcoidosis and immune-mediated necrotizing myopathy: an uncommon coincidence","volume":"2","author":"Martins","year":"2023","journal-title":"ARP Rheumatol"},{"issue":"10","key":"10.1016\/j.nmd.2025.105363_bib0084","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000210001","article-title":"Immune-mediated megaconial myopathy: a novel subtype of autoimmune myopathy","volume":"103","author":"Santilli","year":"2024","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.nmd.2025.105363_bib0085","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1097\/WCO.0b013e328364c82d","article-title":"Megaconial congenital muscular dystrophy due to loss-of-function mutations in choline kinase beta","volume":"26","author":"Mitsuhashi","year":"2013","journal-title":"Curr Opin Neurol"},{"issue":"5","key":"10.1016\/j.nmd.2025.105363_bib0086","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1002\/(SICI)1097-4598(199805)21:5<637::AID-MUS10>3.0.CO;2-S","article-title":"Mitochondrial abnormalities in selenium-deficient myopathy","volume":"21","author":"Osaki","year":"1998","journal-title":"Muscle Nerve"},{"issue":"1","key":"10.1016\/j.nmd.2025.105363_bib0087","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1002\/mus.20740","article-title":"An unusual myopathy: speckled muscle fibers due to enlarged mitochondria","volume":"36","author":"Jeffree","year":"2007","journal-title":"Muscle Nerve"},{"issue":"12","key":"10.1016\/j.nmd.2025.105363_bib0088","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1097\/NEN.0000000000000132","article-title":"Regional ischemic immune myopathy: a paraneoplastic dermatomyopathy","volume":"73","author":"Cai","year":"2014","journal-title":"J Neuropathol Exp Neurol"},{"issue":"15","key":"10.1016\/j.nmd.2025.105363_bib0089","doi-asserted-by":"crossref","first-page":"e1763","DOI":"10.1212\/WNL.0000000000007260","article-title":"Immune myopathy with large histiocyte-related myofiber necrosis","volume":"92","author":"Pestronk","year":"2019","journal-title":"Neurology"}],"container-title":["Neuromuscular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896625000902?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896625000902?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T11:07:24Z","timestamp":1750849644000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960896625000902"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":89,"alternative-id":["S0960896625000902"],"URL":"https:\/\/doi.org\/10.1016\/j.nmd.2025.105363","relation":{},"ISSN":["0960-8966"],"issn-type":[{"value":"0960-8966","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Emerging atypical clinicopathological manifestations of immune-mediated necrotizing myopathy (IMNM)","name":"articletitle","label":"Article Title"},{"value":"Neuromuscular Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nmd.2025.105363","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"105363"}}